Sign in

NCT03606161Active, not recruiting

Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain Tumors

Feasibility of Navigated Repetitive Transcranial Magnetic Stimulation (nrTMS) to Augment the Effects of Motor Rehabilitation in Brain Tumor Patients

Source: ClinicalTrials.gov · Last updated 11 Aug 2026

Brief summary (registry, in English)

This trial studies how well navigated repetitive transcranial magnetic stimulation works in improving motor rehabilitation in participants with brain tumors. Navigated repetitive transcranial magnetic stimulation may help improve patients' lost motor function after surgery.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
32 (actual)
First submitted
20 Jul 2018
Start date
23 Aug 2018
Primary completion date
31 Dec 2027
Lead sponsor
M.D. Anderson Cancer Center
NCT number
NCT03606161

What you commit to

  • Study type: Interventional
  • Participants enrolled: 32
  • From 23 Aug 2018 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who are taking any antipsychotic medications

Other illness

  • Patients who have ever been diagnosed with bipolar disorder or schizophrenia
  • Patients with a history of stroke

Who the study is looking for

  • Patients with brain tumors associated with the motor cortex
  • Understand and read English, sign a written informed consent, and be willing to follow protocol requirements
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
  • Motor impairment must be related to the surgical procedure or the tumor itself (in the opinion of the treating physician)
  • Patients who are within 7 days of brain tumor resection associated with the motor cortex
  • Eligibility for the nrTMS treatment will be based on motor ability and will be determined postoperatively by the surgeon

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
M D Anderson Cancer Center
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.